XML 17 R5.htm IDEA: XBRL DOCUMENT v3.21.2
INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
9 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Cash Flows used in Operating Activities    
Net loss $ (26,190,428) $ (20,315,244)
Adjustments to reconcile net loss to net cash used in operations:    
Stock-based compensation 5,079,395 4,216,306
Changes in non-cash working capital balances related to operations:    
Incentive and tax receivables (3,751,918) (905,227)
Prepaid expenses and deposits 185,641 62,367
Accounts payable 187,653 456,872
Accrued liabilities 1,336,660 1,452,652
Deferred grant income 443,831 0
Net cash used in operating activities (22,709,166) (15,032,274)
Cash Flows provided by Financing Activities    
Issuance of common shares 153,218,758 20,490,297
Share issue costs (5,533,473) (24,508)
Proceeds from exercise of warrants 1,466,500 0
Proceeds from exercise of stock options 1,868,408 0
Net cash provided by financing activities 151,020,193 20,465,789
Increase in cash and cash equivalents during the period 128,311,027 5,433,515
Cash and cash equivalents, beginning of period 29,249,018 22,185,630
Cash and cash equivalents, end of period $ 157,560,045 $ 27,619,145